Background: The aim of this study was to evaluate the change in the position of totally implantable central venous catheters(TIVC) tips in patients with mammary hypertrophy, comparing them to patients without this condition in both the supine and upright position. Methods: This was a prospective study involving consecutive patients who underwent the implantation of totally implantable central venous catheters (TIVC) in internal jugular or subclavian veins with reservoir placement on the thoracic wall. Data were collected with regard to demographic and clinical features of the included patients, including: age (years), height (cm), weight (Kg), BMI, malignancy type, occurrence of previous non-deforming procedures to the breasts, presence of a Peripherally Inserted Central Catheter (PICC) during TIVC implantation, and history of DVT (punctured vein and laterality). The catheter tip's position in an upright stance was documented through a routine postoperative chest X-ray, using a posterior-to-anterior incidence technique, also including a radiopaque ruler permitting the measuring of its distance from the carina in centimetres. The intraclass correlation coefficient between the intraoperative and postoperative distance variation recorded by Observers 1 and 2 was excellent (r =0.773). Results: Significant caudal TIVC tip displacement was determined by previous nondeforming surgery to the chest wall (p=0.002); and significant proximal displacement was calculated by the presence of PICC during TIVC implantation (p =0.042). The Sacchini index did not exhibit a significant association with changes in catheter tip locations after surgery. Conclusion: Significant caudal TIVC tip displacement was determined by previous non-deforming surgery to the thoracic wall (p=0.002); and significant proximal displacement was determined by the presence of a PICC during TIVC implantation (p=0.042). Mammary hypertrophy, as assessed by the Sacchini index, was not statistically correlated to catheter tip displacement (p=0.612).

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee / IRB of Hospital Israelita Albert Einstein gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors.